Dan Frigo, University of Houston (IMAGE)
Caption
Receiving two grants within a week of each other, Dan Frigo is targeting two different mechanisms that play a role in prostate cancer. Both focus on a cascade of biochemical reactions inside cells, downstream of a protein called the androgen receptor (AR).
Credit
Jessie Villarreal
Usage Restrictions
None
License
Licensed content